Replies to post #18529 on Titan Medical Inc (TMDIF)

[devicerep888]

Either you wait it out or you sell. You can discuss what happened all day long, but its in the past and it happened. Titan still has a massive opportunity. If they have the right technology the market will wait for them to bring it. They just better hope no one beats them to the punch. This is and always has been a long term investment for me. I don't day trade and try to time the market. For those who do, I can see this being frustrating, but you also knew what you were getting into. High risk high reward.

[elcaribes]

None of us like where the stock is priced. Technicals are horrible and we now have a longer time frame. - not much different from a company missing on earnings because of events unforeseen. I agree with devicerep - wait it out or sell and quit beating a dead bush. Titan is oversold now and still in the grips of bearish technicals - eventually it will swing the other direction.

[Geo2014]

Is this what the next two years on this board is going to bring? How often are we going to re-visit this? If you are unhappy you should get out of the stock! It is a development company on an OTC exchange. There is considerable risk. Not sure what whining about Titan's change of plans is going to accompish! They feel it is a better strategy. If you do not, then you should reconsider your investment.

[was CUIN2]

Perhaps many longterm investors are puzzled by the extended timeline and probably questioning the logic, which is acceptable to me. You can argue the merits of a SPORT System with 1 surgical indication vs 10. and the delay in real PPS appreciation due to the extended timeline. But have your facts straight.

First, they didn't change course, but added more indications thereby extending the timeline. Changing course would be, "We stopped working on SPORT and are now focusing on miniature robot bugs that can enter through the bloodstream".

Second, deception is a strong word. I do not believe shareholders have been deceived. If you take the time to read the company prospectus, you'll see the very real risk in this speculative stock made perfectly clear.

Third, the final SPORT product will ultimately be worth much more than before the addition of the new indications. It's just gonna be a bit longer.

I would argue that a SPORT System with 10 surgical indications could have a PPS 2-3 times higher one year from release, than a SPORT System with 1 surgical indication in the year it's being released (if the market isn't receptive of course). From what we understand, that could have been our reality.

Good luck in any case.